Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director

Apexigen, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/23/2023 8-K Appointed a new director
Docs: "THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATIONOF",
"BYLAWS OFPYXIS ONCOLOGY ACQUISITION CORP., A DELAWARE CORPORATION BYLAWS OFPYXIS ONCOLOGY ACQUISITION CORP. ARTICLE I"
08/23/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/22/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/18/2023 8-K Quarterly results
08/16/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/15/2023 8-K Other Events  Interactive Data
08/11/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/11/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
06/30/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/30/2023 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
05/25/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/24/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/24/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/24/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/24/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Agreement and Plan of Merger, by and among Pyxis Oncology, Inc., Ascent Merger Sub Corp. and Apexigen, Inc",
"Form of Voting Agreement",
"Pyxis Oncology to Acquire Apexigen"
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/04/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
04/04/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/22/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/21/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
03/17/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
02/27/2023 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "Apexigen Announces Review of Strategic Alternatives and Restructuring"
02/22/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
02/22/2023 10-K Annual Report for the period ended December 31, 2022
02/14/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/01/2023 8-K Quarterly results
01/30/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
01/30/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
01/26/2023 SC 13G/A Kepos Capital LP reports a 0% stake in Apexigen, Inc.
01/25/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Form of Common Stock Purchase Warrant",
"Form of Placement Agent Warrant",
"Form of Securities Purchase Agreement",
"Form of Registration Rights Agreement",
"Apexigen Announces Approximately $2.8 Million Private Placement Financing"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy